Ignite Creation Date:
2025-12-24 @ 4:25 PM
Ignite Modification Date:
2026-01-29 @ 3:27 PM
Study NCT ID:
NCT03743766
Status:
COMPLETED
Last Update Posted:
2024-09-25
First Post:
2018-10-18
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Nivolumab, BMS-936558 in Combination with Relatlimab, BMS-986016 in Patients with Metastatic Melanoma Naïve to Prior Immunotherapy in the Metastatic Setting
Sponsor:
John Kirkwood
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2019-03-29
Start Date Type:
ACTUAL
Primary Completion Date:
2024-07-03
Primary Completion Date Type:
ACTUAL
Completion Date:
2024-07-03
Completion Date Type:
ACTUAL
First Submit Date:
2018-10-18
First Submit QC Date:
None
Study First Post Date:
2018-11-16
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2024-09-23
Last Update Post Date:
2024-09-25
Last Update Post Date Type:
ACTUAL